Literature DB >> 8934574

High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters.

S R Himes1, L S Coles, R Reeves, M F Shannon.   

Abstract

CD28 response elements (CD28REs) within cytokine promoters are variant NF-kappaB-binding sites and are essential for transcription in response to CD28 receptor activation in T cells. We show that the CK-1 element (CD28RE) within the GM-CSF promoter binds the RelA and c-Rel transcription factors in response to CD28 activation. We further show that the high mobility group protein HMG I(Y) can bind to the CD28REs of both GM-CSF and IL-2 and that this binding is critical for c-Rel, but not RelA, binding. A second NF-kappaB site in the GM-CSF promoter that binds p50 and RelA, but neither c-Rel nor HMG I(Y), failed to respond to CD28 activation. Expression of HMG I or c-Rel antisense RNA inhibited CD28 activation of the IL-2 and GM-CSF promoters, implying that HMG I(Y) enhancement of c-Rel binding plays an important role in the activity of the CD28REs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8934574     DOI: 10.1016/s1074-7613(00)80503-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  30 in total

Review 1.  Selectivity of the NF-{kappa}B response.

Authors:  Ranjan Sen; Stephen T Smale
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-14       Impact factor: 10.005

2.  Construction and analysis of cells lacking the HMGA gene family.

Authors:  Brett Beitzel; Frederic Bushman
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

3.  NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C.

Authors:  F Mantovani; S Covaceuszach; A Rustighi; R Sgarra; C Heath; G H Goodwin; G Manfioletti
Journal:  Nucleic Acids Res       Date:  1998-03-15       Impact factor: 16.971

4.  The human granulocyte-macrophage colony-stimulating factor gene is autonomously regulated in vivo by an inducible tissue-specific enhancer.

Authors:  P N Cockerill; A G Bert; D Roberts; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 5.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

6.  Intra- and intermolecular cooperative binding of high-mobility-group protein I(Y) to the beta-interferon promoter.

Authors:  J Yie; S Liang; M Merika; D Thanos
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

7.  CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.

Authors:  V S Shapiro; K E Truitt; J B Imboden; A Weiss
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

8.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

9.  The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.

Authors:  J Yie; M Merika; N Munshi; G Chen; D Thanos
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

10.  HMGA1a recognition candidate DNA sequences in humans.

Authors:  Takayuki Manabe; Taiichi Katayama; Masaya Tohyama
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.